Mcp-Ratiopharm

Metoclopramide, the active ingredient in Mcp‑Ratiopharm, is a dopamine D2 receptor antagonist presented as a tablet for oral use. It is employed to relieve nausea and vomiting, prevent postoperative nausea, improve gastric emptying in gastroparesis, reduce reflux symptoms in GERD, and alleviate migraine‑associated nausea in adult patients.

GNH USA supplies Mcp‑Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance and reliable delivery across multiple regions, and supporting local healthcare partners with technical assistance.

Metoclopramide is used to manage conditions related to nausea, vomiting and delayed gastric motility.

- Nausea and vomiting: reduces frequency and severity of episodes. - Postoperative nausea and vomiting: prevents and treats nausea after surgery. - Gastroparesis: enhances gastric emptying and eases related symptoms. - Gastroesophageal reflux disease (GERD): decreases reflux episodes by improving motility. - Migraine‑associated nausea: alleviates nausea accompanying migraine attacks.

Metoclopramide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general lack of energy. - Diarrhea: loose, frequent stools. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Extrapyramidal reactions (e.g., dystonia): involuntary muscle contractions. - Tardive dyskinesia: persistent, irreversible movement disorder. - Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity.

When prescribing Metoclopramide, consider the following precautions.

- Assess renal function: adjust use in severe renal impairment. - Monitor for extrapyramidal symptoms: discontinue if they appear. - Avoid in patients with known hypersensitivity to metoclopramide. - Use caution in patients with depression or suicidal ideation. - Pregnancy and lactation: evaluate risk–benefit as safety data are limited. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Metoclopramide can interact with several drug classes; awareness helps mitigate risks.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive central nervous system depression. - CYP2D6 inhibitors (e.g., fluoxetine): increase metoclopramide plasma levels. - Levodopa: may reduce its therapeutic efficacy.

Moderate Interactions (Monitor Closely): - Anticholinergics: may diminish pro‑kinetic effect. - Other dopamine antagonists: increase risk of extrapyramidal symptoms. - MAO inhibitors: potential for hypertensive crisis.